Hematopoietic Cell Growth Factors
"Hematopoietic Cell Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
| Descriptor ID |
D016298
|
| MeSH Number(s) |
D12.644.276.374.410 D12.776.467.374.410 D23.529.374.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Cell Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Cell Growth Factors".
This graph shows the total number of publications written about "Hematopoietic Cell Growth Factors" by people in this website by year, and whether "Hematopoietic Cell Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1997 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Cell Growth Factors" by people in Profiles.
-
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment. Exp Hematol. 2020 11; 91:39-45.e2.
-
Noncanonical NF-?B pathway controls the production of type I interferons in antiviral innate immunity. Immunity. 2014 Mar 20; 40(3):342-54.
-
Twenty-five years of peripheral blood stem cell transplantation. Blood. 2011 Jun 16; 117(24):6411-6.
-
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008 Sep; 48(9):2008-25.
-
Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. J Clin Oncol. 2005 Dec 01; 23(34):8620-8.
-
Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol. 2005 Mar 01; 174(5):3067-71.
-
Future directions with hematopoietic growth factors. J Natl Compr Canc Netw. 2003 Jan; 1 Suppl 1:S96-101.
-
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Blood. 2002 Dec 15; 100(13):4391-400.
-
Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am. 2001 Aug; 15(4):723-40, ix.
-
Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. Biol Blood Marrow Transplant. 1997 Nov; 3(5):273-81.